Old Web
English
Sign In
Acemap
>
authorDetail
>
Phillip F. Pratt
Phillip F. Pratt
Rensselaer Polytechnic Institute
Internal medicine
Endocrinology
Chemistry
Phosphodiesterase inhibitor
Zaprinast
5
Papers
74
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats
1993
European Journal of Pharmacology
Lawrence De Garavilla
Marlo L. Volberg
Phillip F. Pratt
Paul J. Silver
R.Allan Buchholz
Show All
Source
Cite
Save
Citations (12)
Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast
1991
European Journal of Pharmacology
Paul J. Silver
Edward D. Pagani
Lawrence de Garavilla
Glenn S. VanAller
Marlo L. Volberg
Phillip F. Pratt
R.Allan Buchholz
Show All
Source
Cite
Save
Citations (25)
Effects of nucleotide cyclase activators on the depressor response to selective low Km cyclic AMP phosphodiesterase inhibitors in rats
1991
Drug Development Research
Ronald L. Dundoreph
Phillip F. Pratt
Wendy D. Hallenbeck
Paul J. Silver
R.Allan Buchholz
Show All
Source
Cite
Save
Citations (1)
Nω-Nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast
1991
European Journal of Pharmacology
Ronald L. Dundore
Phillip F. Pratt
Bernard OConnor
R.Allan Buchholz
Edward D. Pagani
Show All
Source
Cite
Save
Citations (17)
Sodium nitroprusside potentiates the depressor response to the phosphodiesterase inhibitor zaprinast in rats
1990
European Journal of Pharmacology
Ronald L. Dundore
Phillip F. Pratt
Wendy D. Hallenbeck
Marlo L. Wassey
Paul J. Silver
R.Allan Buchholz
Show All
Source
Cite
Save
Citations (19)
1